H.R. 2296 · 116th Congress

Fair Accountability and Innovative Research Drug Pricing Act of 2019

Stage
Reported from committee
Sponsor
Jan Schakowsky
Introduced
2019-04-12
Latest action
2019-09-24 · Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-215.

Action history

  1. 2019-09-24Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-215.
  2. 2019-09-24Placed on the Union Calendar, Calendar No. 170.
  3. 2019-07-17Committee Consideration and Mark-up Session Held.
  4. 2019-07-17Ordered to be Reported (Amended) by Voice Vote.
  5. 2019-07-11Subcommittee Consideration and Mark-up Session Held.
  6. 2019-07-11Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
  7. 2019-05-21Subcommittee Hearings Held.
  8. 2019-04-15Referred to the Subcommittee on Health.
  9. 2019-04-12Introduced in House
  10. 2019-04-12Referred to the House Committee on Energy and Commerce.